Real-Time Blood Glucose CGM Patch Market Report 2026

Real-Time Blood Glucose CGM Patch Market Overview

• Real-Time Blood Glucose CGM Patch market size has reached to $7.05 billion in 2025 • Expected to grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: The Rising Remote Monitoring And Telehealth Adoption Are Driving The Market Due To Demand For Convenient Diabetes Management • Market Trend: Innovative Water-Resistant Sensor Enhances User Convenience • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Real-Time Blood Glucose CGM Patch Market?

A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable medical device that continuously measures glucose levels in the interstitial fluid just beneath the skin and provides real-time data. It helps individuals with diabetes monitor their blood sugar trends, detect fluctuations, and make timely adjustments to insulin or diet for better glycemic control. These patches reduce the need for frequent finger-prick testing while enabling proactive glucose control. The main product types of real-time blood continuous glucose monitoring (CGM) patch are wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch refers to a digital health device that continuously tracks glucose levels in real-time through a sensor applied to the skin, helping manage diabetes, improve glycemic control, and support personalized treatment decisions. It utilizes various technologies such as enzymatic and non-enzymatic sensors, and is applied across various diabetes conditions such as type 1 diabetes, type 2 diabetes, gestational diabetes, and others. It is distributed through multiple channels, such as online pharmacies, retail pharmacies, hospital pharmacies, and others, serving end users such as hospitals and clinics, homecare settings, diagnostic centers, and others.

What Is The Real-Time Blood Glucose CGM Patch Market Growth Forecast?

The real-time blood glucose cgm patch market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to AI-based glucose prediction, telehealth integration, preventive diabetes management, remote patient monitoring expansion, reimbursement policy support. Major trends in the forecast period include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, long-duration wearable patches, improved sensor accuracy.

Global Real-Time Blood Glucose CGM Patch Market Segmentation

1) By Product Type: Wearable Continuous Glucose Monitoring Patch, Implantable Continuous Glucose Monitoring Patch 2) By Technology: Enzymatic, Non-Enzymatic 3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications 4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels 5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users Subsegments: 1) By Wearable Continuous Glucose Monitoring Patch: Arm Patches, Abdominal Patches 2) By Implantable Continuous Glucose Monitoring Patch: Short-Term Implantable Patches, Long-Term Implantable Patches

What Is The Driver Of The Real-Time Blood Glucose CGM Patch Market?

The rising remote monitoring and telehealth adoption are expected to propel the growth of the real-time blood glucose CGM patch market going forward. Remote monitoring refers to the use of digital technologies to collect and transmit a patient's health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for ongoing assessment and management. Telehealth adoption, on the other hand, involves the increasing use of virtual healthcare services, including video consultations, remote follow-ups, and digital communication between patients and providers. Rising remote monitoring and telehealth adoption are increasing due to the growing demand for convenient and accessible healthcare services, especially for managing chronic conditions like diabetes. The real-time blood glucose CGM patch supports rising remote monitoring and telehealth adoption by enabling continuous, real-time data sharing with healthcare providers, allowing for timely interventions and virtual diabetes management. For instance, in February 2025, according to the American Hospital Association (AHA), a US-based national organization, the United States is projected to experience a shortage of up to 86,000 physicians by 2036, highlighting the critical role of telehealth in addressing this growing healthcare gap. Therefore, the rising remote monitoring and telehealth adoption are driving the growth of the real-time blood glucose CGM patch industry.

Key Players In The Global Real-Time Blood Glucose CGM Patch Market

Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.

Global Real-Time Blood Glucose CGM Patch Market Trends and Insights

Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are focusing on developing innovative products, such as water-resistant sensors, to enhance user convenience and continuous monitoring reliability. A water-resistant sensor is a device designed to function accurately and continuously even when exposed to water or sweat, protecting its internal components from damage. For instance, in February 2024, Dexcom Inc., a US-based medical device company, launched the Dexcom ONE+, a real-time continuous glucose monitoring (CGM) system in Spain, Belgium, and Poland. The system offers a smaller, more accurate, and user-friendly CGM solution that provides continuous real-time glucose data 24/7 with customizable alerts, including a unique delay-first high feature to reduce alarm fatigue. It incorporates an all-in-one water-resistant sensor suitable for multiple wear locations, a rapid 30-minute warm-up, a 10-day sensor lifespan with a 12-hour grace period for sensor changes, and seamless connectivity to smartphones and receivers, supporting comprehensive diabetes management.

What Are Latest Mergers And Acquisitions In The Real-Time Blood Glucose CGM Patch Market?

In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health Inc. aims to expand its at-home solutions business to serve more patients with innovative diabetes care at home, accelerate growth in the growing diabetes population, and enhance its patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that offers a real-time blood glucose CGM patch.

Regional Outlook

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Real-Time Blood Glucose CGM Patch Market?

The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.